KI-DX-014
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-175238-5MG | 5 mg | 834,00 | Add | |
| HY-175238-1ML | 10mM/1mL | 915,00 | Add | |
| HY-175238-10MG | 10 mg | 1'324,00 | Add | |
| HY-175238-25MG | 25 mg | 2'629,00 | Add | |
| HY-175238-50MG | 50 mg | 4'192,00 | Add | |
| HY-175238-100MG | 100 mg | 6'697,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
KI-DX-014 is a DDX21 inhibitor with an IC50 of 3.31 μM. KI-DX-014 significantly inhibits the DDX21-RNA interaction and modulates ATPase activity and biomolecular condensate formation. KI-DX-014 reduces the DDX21-dependent release of P-TEFb from the 7SK snRNP complex, inhibits P-TEFb-dependent phosphorylation of the RNA polymerase II CTD, and induces developmental defects in zebrafish embryos. KI-DX-014 can be used for cancers and neurodegenerative disorders research[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Neurological Disease |
| Grade | Clinical information: No Development Reported |
| Molecular Formula | C17H22N4O3 |
| Molecular Weight | 330.38 |
| CAS-Number | 1309288-83-2 |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room temperature |
| Material Safety Data Sheet | Download PDF |